Haemostasis Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

2017-09-12
Price :
Published : Sep-2017
No. of Pages : 259
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Haemostasis Diagnostic Tests Overview 13
3 Products under Development 14
3.1 Haemostasis Diagnostic Tests - Pipeline Products by Stage of Development 14
3.2 Haemostasis Diagnostic Tests - Pipeline Products by Segment 15
3.3 Haemostasis Diagnostic Tests - Pipeline Products by Territory 16
3.4 Haemostasis Diagnostic Tests - Pipeline Products by Regulatory Path 17
3.5 Haemostasis Diagnostic Tests - Pipeline Products by Estimated Approval Date 18
4 Haemostasis Diagnostic Tests - Pipeline Products under Development by Companies 19
4.1 Haemostasis Diagnostic Tests Companies - Pipeline Products by Stage of Development 19
4.2 Haemostasis Diagnostic Tests - Pipeline Products by Stage of Development 21
5 Haemostasis Diagnostic Tests Companies and Product Overview 26
5.1 Alere Inc Company Overview 26
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Analyticon Biotechnologies AG Company Overview 27
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 27
5.3 Bio-AMD Inc Company Overview 33
5.3.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.4 BioMedica USA LLC Company Overview 34
5.4.1 BioMedica USA LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Braun Biosystems, Inc. Company Overview 35
5.5.1 Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Diagnostica Stago Inc Company Overview 36
5.6.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 ELITechGroup Inc Company Overview 42
5.7.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 Emosis SAS Company Overview 43
5.8.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 43
5.9 Grifols Inc Company Overview 44
5.9.1 Grifols Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.10 Grifols SA Company Overview 46
5.10.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 46
5.11 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 60
5.11.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Helena Laboratories Corp. Company Overview 61
5.12.1 Helena Laboratories Corp. Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 HemoSonics, LLC Company Overview 67
5.13.1 HemoSonics, LLC Pipeline Products & Ongoing Clinical Trials Overview 67
5.14 Hologic Inc Company Overview 73
5.14.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 73
5.15 Instrumentation Laboratory Company Company Overview 74
5.15.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 74
5.16 Massachusetts General Hospital Company Overview 89
5.16.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 89
5.17 Nexus Medical, LLC Company Overview 90
5.17.1 Nexus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 90
5.18 Novametics, Inc. Company Overview 91
5.18.1 Novametics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.19 Pakwa Technologies Company Overview 92
5.19.1 Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview 92
5.20 PortaScience Inc Company Overview 93
5.20.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 93
5.21 Radiometer Medical ApS Company Overview 94
5.21.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 94
5.22 Rappaport Family Institute for Research in the Medical Science Company Overview 96
5.22.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview 96
5.23 rHealth Company Overview 97
5.23.1 rHealth Pipeline Products & Ongoing Clinical Trials Overview 97
5.24 Roche Diagnostics International Ltd Company Overview 98
5.24.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 98
5.25 SATT Conectus Alsace SAS Company Overview 100
5.25.1 SATT Conectus Alsace SAS Pipeline Products & Ongoing Clinical Trials Overview 100
5.26 Sekisui Medical Co Ltd Company Overview 101
5.26.1 Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101
5.27 Siemens Healthcare GmbH Company Overview 102
5.27.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 102
5.28 SonoMedix, Inc. Company Overview 125
5.28.1 SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.29 SQI Diagnostics Inc Company Overview 126
5.29.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 126
5.30 Stichting Lygature Company Overview 127
5.30.1 Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview 127
5.31 Sysmex Corp Company Overview 129
5.31.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 129
5.32 Tarabios Company Overview 133
5.32.1 Tarabios Pipeline Products & Ongoing Clinical Trials Overview 133
5.33 Transfusion & Transplantation Technologies (Inactive) Company Overview 134
5.33.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 134
5.34 Universal Biosensors Inc Company Overview 135
5.34.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 135
5.35 University of Colorado Company Overview 136
5.35.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 136
5.36 University of Michigan Company Overview 137
5.36.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 137
5.37 University of Texas Health Science Center at Houston Company Overview 138
5.37.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 138
5.38 University of Vermont Company Overview 139
5.38.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 139
6 Haemostasis Diagnostic Tests - Recent Developments 140
6.1 Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 140
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 141
6.3 Aug 21, 2017: HemaCare Reports Strong First Half 2017 Results 144
6.4 Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group 144
6.5 Aug 07, 2017: Rick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process 145
6.6 Aug 03, 2017: Siemens extends appointment of CEO Joe Kaeser 146
6.7 Aug 03, 2017: Siemens: Earnings Release Q3 FY 2017 146
6.8 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 148
6.9 Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 149
6.10 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 150
6.11 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 152
6.12 Jul 27, 2017: Abcam: Pre-Close Period Update 158
6.13 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 159
6.14 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 161
6.15 Jul 24, 2017: HemaCare Signs Long Term Lease for Facility Relocation and Expansion 163
6.16 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 163
6.17 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 165
6.18 Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 165
6.19 Jun 19, 2017: IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2017 165
6.20 Jun 14, 2017: Abbott Broadens Product Offering in Coagulation With Expanded Launch of the Sekisui CP3000 Fully Automated Coagulation System 166
6.21 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 167
6.22 Jun 12, 2017: Siemens Healthineers Showcases its Atellica Diagnostics Portfolio and POC Informatics Solutions at EuroMedLab 168
6.23 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 169
6.24 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 169
6.25 May 23, 2017: Dan Buchner joins StarFish Medical business advisory board 172
6.26 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 173
6.27 May 18, 2017: Abcam Makes Final Performance-Based AxioMx Milestone Payment 174
6.28 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 174
6.29 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 175
6.30 May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results 176
6.31 May 08, 2017: Commencement of Xprecia Stride Coagulation Analyser sales activities in the US market 177
6.32 May 04, 2017: Siemens: Earnings Release and Financial Results Q2 FY 2017: Another strong quarter - profitable growth continuing 178
6.33 May 03, 2017: Bioscience Division sales increase 15% to drive Grifols' revenue growth by 11% to Euros 1,062 million 180
6.34 May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 184
6.35 May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 186
6.36 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 186
6.37 Apr 27, 2017: Universal Biosensors reports strong growth in revenue and profit in Q1 2017 187
6.38 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 188
6.39 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 190
6.40 Apr 03, 2017: Supervisory Board of Siemens Healthineers ensures management continuity 191
6.41 Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 192
6.42 Mar 20, 2017: IBEX reports results for the second quarter and the six months ended January 31, 2017 192
6.43 Mar 17, 2017: Eva Schulz-Kamm appointed global head of Government Affairs at Siemens 193
6.44 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 193
6.45 Mar 13, 2017: HemaCare Reports Strong, Profitable 2016 Results 195
6.46 Mar 09, 2017: Alere Provides Update on Arriva Medical 196
6.47 Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 196
6.48 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 197
6.49 Feb 28, 2017: Grifols' revenues exceed Euros 4,000 million, driven by +6.5% growth of the Bioscience Division 197
6.50 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 207
6.51 Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results 209
6.52 Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 211
6.53 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 212
6.54 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 213
6.55 Feb 01, 2017: Jim Hagemann Snabe proposed as new Chairman of Siemens' Supervisory Board 213
6.56 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 214
6.57 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 216
6.58 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 218
6.59 Jan 31, 2017: Siemens: First Quarter Results FY 2017 220
6.60 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 221
6.61 Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors 221
6.62 Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 221
6.63 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 222
6.64 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 222
6.65 Jan 04, 2017: Alere Provides Update on Arriva Medical 223
6.66 Dec 28, 2016: Alere Provides Update on Arriva Medical 223
6.67 Dec 16, 2016: IBEX Reports First Quarter Fiscal 2017 Results 224
6.68 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 225
6.69 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 225
6.70 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 226
6.71 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 226
6.72 Nov 22, 2016: Siemens Healthineers Launches Atellica COAG 360 System High-Volume Specialty Hemostasis Analyzer 227
6.73 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 228
6.74 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 230
6.75 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 231
6.76 Nov 10, 2016: Siemens intends to further strengthen its healthcare business 232
6.77 Nov 08, 2016: Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million 232
6.78 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 237
6.79 Nov 04, 2016: IBEX Reports Results for The Year Ended July 31, 2016 237
6.80 Nov 02, 2016: Lak Ananth to head new next47 startup unit 238
6.81 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 239
6.82 Nov 01, 2016: T2 Biosystems Reports Third Quarter Results 240
6.83 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 242
6.84 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 243
6.85 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 245
6.86 Oct 24, 2016: Abcam commits to the lease of a new facility on the Cambridge Biomedical Campus 247
6.87 Oct 11, 2016: Instrumentation Laboratory Launches HemosIL AcuStar VWF:CB Assay In Europe And Other International Markets 248
6.88 Oct 04, 2016: Siemens Receives FDA Clearance of the Xprecia Stride Coagulation Analyzer 248
6.89 Sep 26, 2016: Instrumentation Laboratory Launches HemoHub Intelligent Data Manager Worldwide 249
6.90 Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board 250
6.91 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 250
6.92 Sep 12, 2016: ABCAM: Strong revenue performance enabling investment for future growth 251
7 Appendix 255
7.1 Methodology 256
7.2 About GlobalData 259
7.3 Contact Us 259
7.4 Disclaimer 259

1.1 List of Tables
Table 1: Haemostasis Diagnostic Tests - Pipeline Products by Stage of Development 14
Table 2: Haemostasis Diagnostic Tests - Pipeline Products by Segment 15
Table 3: Haemostasis Diagnostic Tests - Pipeline Products by Territory 16
Table 4: Haemostasis Diagnostic Tests - Pipeline Products by Regulatory Path 17
Table 5: Haemostasis Diagnostic Tests - Pipeline Products by Estimated Approval Date 18
Table 6: Haemostasis Diagnostic Tests Companies - Pipeline Products by Stage of Development 19
Table 7: Haemostasis Diagnostic Tests - Pipeline Products by Stage of Development 21
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 9: Afinion PT Test - Capillary Blood - Product Status 26
Table 10: Afinion PT Test - Capillary Blood - Product Description 26
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 27
Table 12: Coagulyzer 1 - Product Status 27
Table 13: Coagulyzer 1 - Product Description 28
Table 14: Coagulyzer 100 - Product Status 28
Table 15: Coagulyzer 100 - Product Description 29
Table 16: Coagulyzer 2 - Product Status 29
Table 17: Coagulyzer 2 - Product Description 30
Table 18: Coagulyzer 4 - Product Status 30
Table 19: Coagulyzer 4 - Product Description 30
Table 20: Fibrinogen Lyophilisat Coagulation Kit - Product Status 31
Table 21: Fibrinogen Lyophilisat Coagulation Kit - Product Description 31
Table 22: Prothrombin Time Coagulation Reagent - Product Status 31
Table 23: Prothrombin Time Coagulation Reagent - Product Description 32
Table 24: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 25: COAG Test Strip - Product Status 33
Table 26: COAG Test Strip - Product Description 33
Table 27: BioMedica USA LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Table 28: Portable Diagnostic System - Hemostasis - Product Status 34
Table 29: Portable Diagnostic System - Hemostasis - Product Description 34
Table 30: Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 31: Bio6 - Product Status 35
Table 32: Bio6 - Product Description 35
Table 33: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 34: Calibrated Automated Thrombogram - Thrombin Assay - Product Status 36
Table 35: Calibrated Automated Thrombogram - Thrombin Assay - Product Description 37
Table 36: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 37
Table 37: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 37
Table 38: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status 38
Table 39: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description 38
Table 40: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 38
Table 41: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 39
Table 42: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status 39
Table 43: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description 39
Table 44: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 40
Table 45: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 40
Table 46: STA-R Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 40
Table 47: STA-R Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 41
Table 48: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 49: ELITe InGenius - Coagulation Factors Panel - Product Status 42
Table 50: ELITe InGenius - Coagulation Factors Panel - Product Description 42
Table 51: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 43
Table 52: Hypercoagulation Diagnostics Kit - Product Status 43
Table 53: Hypercoagulation Diagnostics Kit - Product Description 43
Table 54: Grifols Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 55: DG-PT - Product Status 44
Table 56: DG-PT - Product Description 44
Table 57: Q Hemostasis Analyzer - Product Status 45
Table 58: Q Hemostasis Analyzer - Product Description 45
Table 59: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 46
Table 60: DG-APC - Product Status 47
Table 61: DG-APC - Product Description 47
Table 62: DG-Chrom Hep - Product Status 47
Table 63: DG-Chrom Hep - Product Description 48
Table 64: DG-Chrom PC - Product Status 48
Table 65: DG-Chrom PC - Product Description 48
Table 66: Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human - Product Status 49
Table 67: Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human - Product Description 49
Table 68: Hemostasis Reagent Kit - DG-FII - Product Status 49
Table 69: Hemostasis Reagent Kit - DG-FII - Product Description 49
Table 70: Hemostasis Reagent Kit - DG-FIX - Product Status 50
Table 71: Hemostasis Reagent Kit - DG-FIX - Product Description 50
Table 72: Hemostasis Reagent Kit - DG-FV - Product Status 50
Table 73: Hemostasis Reagent Kit - DG-FV - Product Description 51
Table 74: Hemostasis Reagent Kit - DG-FVII - Product Status 51
Table 75: Hemostasis Reagent Kit - DG-FVII - Product Description 51
Table 76: Hemostasis Reagent Kit - DG-FVIII - Product Status 52
Table 77: Hemostasis Reagent Kit - DG-FVIII - Product Description 52
Table 78: Hemostasis Reagent Kit - DG-FX - Product Status 52
Table 79: Hemostasis Reagent Kit - DG-FX - Product Description 52
Table 80: Hemostasis Reagent Kit - DG-FXI - Product Status 53
Table 81: Hemostasis Reagent Kit - DG-FXI - Product Description 53
Table 82: Hemostasis Reagent Kit - DG-FXII - Product Status 53
Table 83: Hemostasis Reagent Kit - DG-FXII - Product Description 54
Table 84: Hemostasis Reagent Kit - DG-Latex D Dimer - Product Status 54
Table 85: Hemostasis Reagent Kit - DG-Latex D Dimer - Product Description 54
Table 86: Hemostasis Reagent Kit - DG-Latex VWF: Gp1b - Product Status 55
Table 87: Hemostasis Reagent Kit - DG-Latex VWF: Gp1b - Product Description 55
Table 88: Hemostasis Reagent Kit - DG-PT RecombiLIQ - Product Status 55
Table 89: Hemostasis Reagent Kit - DG-PT RecombiLIQ - Product Description 56
Table 90: Hemostasis Reagent Kit - DG-TT L Human - Product Status 56
Table 91: Hemostasis Reagent Kit - DG-TT L Human - Product Description 56
Table 92: Thrombophilia Reagent Kit - DG-Chrom Anti Xa - Product Status 56
Table 93: Thrombophilia Reagent Kit - DG-Chrom Anti Xa - Product Description 57
Table 94: Thrombophilia Reagent Kit - DG-Chrom AT L - Product Status 57
Table 95: Thrombophilia Reagent Kit - DG-Chrom AT L - Product Description 57
Table 96: Thrombophilia Reagent Kit - DG-Clot PS - Product Status 58
Table 97: Thrombophilia Reagent Kit - DG-Clot PS - Product Description 58
Table 98: Thrombophilia Reagent Kit - DG-DRVVT - Product Status 58
Table 99: Thrombophilia Reagent Kit - DG-DRVVT - Product Description 58
Table 100: Thrombophilia Reagent Kit - DG-DRVVT Confirm - Product Status 59
Table 101: Thrombophilia Reagent Kit - DG-DRVVT Confirm - Product Description 59
Table 102: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 60
Table 103: Hemostasis Monitoring Microfluidic Device - Product Status 60
Table 104: Hemostasis Monitoring Microfluidic Device - Product Description 60
Table 105: Helena Laboratories Corp. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 106: Actalyke Mini II - APTT Test - Product Status 61
Table 107: Actalyke Mini II - APTT Test - Product Description 61
Table 108: Actalyke Mini II - LMWH Test - Product Status 62
Table 109: Actalyke Mini II - LMWH Test - Product Description 62
Table 110: Actalyke Mini II - PT Test - Product Status 62
Table 111: Actalyke Mini II - PT Test - Product Description 62
Table 112: Actalyke XL - APTT Test - Product Status 63
Table 113: Actalyke XL - APTT Test - Product Description 63
Table 114: Actalyke XL - Heparin Test - Product Status 63
Table 115: Actalyke XL - Heparin Test - Product Description 63
Table 116: Actalyke XL - LMWH Test - Product Status 64
Table 117: Actalyke XL - LMWH Test - Product Description 64
Table 118: Actalyke XL - PT Test - Product Status 64
Table 119: Actalyke XL - PT Test - Product Description 64
Table 120: Cascade Abrazo Analyzer - Product Status 65
Table 121: Cascade Abrazo Analyzer - Product Description 65
Table 122: Cascade M - DRVVT Test - Product Status 65
Table 123: Cascade M - DRVVT Test - Product Description 66
Table 124: Cascade M-4 - DRVVT Test - Product Status 66
Table 125: Cascade M-4 - DRVVT Test - Product Description 66
Table 126: HemoSonics, LLC Pipeline Products & Ongoing Clinical Trials Overview 67
Table 127: HemoSonics Global Hemostasis Analyzer - Chronic Liver Disease - Product Status 67
Table 128: HemoSonics Global Hemostasis Analyzer - Chronic Liver Disease - Product Description 68
Table 129: HemoSonics Global Hemostasis Analyzer - Intensive Care - Product Status 68
Table 130: HemoSonics Global Hemostasis Analyzer - Intensive Care - Product Description 68
Table 131: HemoSonics Global Hemostasis Analyzer - Neurosurgery - Product Status 69
Table 132: HemoSonics Global Hemostasis Analyzer - Neurosurgery - Product Description 69
Table 133: HemoSonics Global Hemostasis Analyzer - Oral Contraception - Product Status 69
Table 134: HemoSonics Global Hemostasis Analyzer - Oral Contraception - Product Description 70
Table 135: HemoSonics Global Hemostasis Analyzer - Orthopedic Surgery - Product Status 70
Table 136: HemoSonics Global Hemostasis Analyzer - Orthopedic Surgery - Product Description 70
Table 137: HemoSonics Global Hemostasis Analyzer - Perinatal Care - Product Status 71
Table 138: HemoSonics Global Hemostasis Analyzer - Perinatal Care - Product Description 71
Table 139: HemoSonics Global Hemostasis Analyzer - Trauma - Product Status 71
Table 140: HemoSonics Global Hemostasis Analyzer - Trauma - Product Description 72
Table 141: HemoSonics Global Hemostasis Analyzer HS-GHA - Product Status 72
Table 142: HemoSonics Global Hemostasis Analyzer HS-GHA - Product Description 72
Table 143: Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 144: Diagnostic Assay - Coagulation Disorders - Product Status 73
Table 145: Diagnostic Assay - Coagulation Disorders - Product Description 73
Table 146: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 74
Table 147: ACL AcuStar - aß2GPI Domain I Assay - Product Status 75
Table 148: ACL AcuStar - aß2GPI Domain I Assay - Product Description 75
Table 149: ACL AcuStar - HIT IgG Test - Product Status 75
Table 150: ACL AcuStar - HIT IgG Test - Product Description 76
Table 151: ACL AcuStar - HIT Total ab Test - Product Status 76
Table 152: ACL AcuStar - HIT Total ab Test - Product Description 76
Table 153: ACL AcuStar - VWF: RCo Assay - Product Status 77
Table 154: ACL AcuStar - VWF: RCo Assay - Product Description 77
Table 155: ACL AcuStar - VWF:Ag Assay - Product Status 77
Table 156: ACL AcuStar - VWF:Ag Assay - Product Description 78
Table 157: ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Status 78
Table 158: ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Description 78
Table 159: ACL TOP 300 CTS System - HIT Assay - Product Status 78
Table 160: ACL TOP 300 CTS System - HIT Assay - Product Description 79
Table 161: ACL TOP 300 CTS System - VWF-Ristocetin Cofactor - Product Status 79
Table 162: ACL TOP 300 CTS System - VWF-Ristocetin Cofactor - Product Description 79
Table 163: ACL TOP 350 CTS System - VWF (Ristocetin Cofactor) Assay - Product Status 80
Table 164: ACL TOP 350 CTS System - VWF (Ristocetin Cofactor) Assay - Product Description 80
Table 165: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Status 80
Table 166: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Description 80
Table 167: ACL TOP 500 CTS System - HIT Test - Product Status 81
Table 168: ACL TOP 500 CTS System - HIT Test - Product Description 81
Table 169: ACL TOP 500 CTS System - VWF - Ristocetin Cofactor - Product Status 81
Table 170: ACL TOP 500 CTS System - VWF - Ristocetin Cofactor - Product Description 82
Table 171: ACL TOP 550 CTS System - VWF (Ristocetin Cofactor) Assay - Product Status 82
Table 172: ACL TOP 550 CTS System - VWF (Ristocetin Cofactor) Assay - Product Description 82
Table 173: ACL TOP 700 - HIT Test - Product Status 83
Table 174: ACL TOP 700 - HIT Test - Product Description 83
Table 175: ACL TOP 700 CTS System - VWF - Ristocetin Cofactor - Product Status 83
Table 176: ACL TOP 700 CTS System - VWF - Ristocetin Cofactor - Product Description 83
Table 177: ACL TOP 700 System - Global Protein C Pathway Test - Product Status 84
Table 178: ACL TOP 700 System - Global Protein C Pathway Test - Product Description 84
Table 179: ACL TOP 750 CTS System - VWF (Ristocetin Cofactor) Assay - Product Status 84
Table 180: ACL TOP 750 CTS System - VWF (Ristocetin Cofactor) Assay - Product Description 84
Table 181: Dabigatran Direct Thrombin Inhibitor Assay - Product Status 85
Table 182: Dabigatran Direct Thrombin Inhibitor Assay - Product Description 85
Table 183: HemoSIL ACL AcuStar - VWF:CB Assay - Product Status 85
Table 184: HemoSIL ACL AcuStar - VWF:CB Assay - Product Description 86
Table 185: HemosIL AcuStar HIT-IgG (PF4-H) Assay - Product Status 86
Table 186: HemosIL AcuStar HIT-IgG (PF4-H) Assay - Product Description 86
Table 187: HemosIL Apixaban Testing Assay - Product Status 87
Table 188: HemosIL Apixaban Testing Assay - Product Description 87
Table 189: HemosIL FDP Assay - Product Status 87
Table 190: HemosIL FDP Assay - Product Description 88
Table 191: Rivaroxaban Liquid Anti-Xa Assay - Product Status 88
Table 192: Rivaroxaban Liquid Anti-Xa Assay - Product Description 88
Table 193: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 89
Table 194: High Throughput Screening Assay - Fibrin-Binding Probes - Product Status 89
Table 195: High Throughput Screening Assay - Fibrin-Binding Probes - Product Description 89
Table 196: Nexus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 90
Table 197: ProTime InRhythm - Product Status 90
Table 198: ProTime InRhythm - Product Description 90
Table 199: Novametics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
Table 200: Blood Coagulation Diagnostic Assay - Product Status 91
Table 201: Blood Coagulation Diagnostic Assay - Product Description 91
Table 202: Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview 92
Table 203: Platelet ActiSense - Product Status 92
Table 204: Platelet ActiSense - Product Description 92
Table 205: PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 93
Table 206: PortaPT - Product Status 93
Table 207: PortaPT - Product Description 93
Table 208: Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 94
Table 209: AQT90 - APTT Test - Product Status 94
Table 210: AQT90 - APTT Test - Product Description 94
Table 211: AQT90 - PT-INR Test - Product Status 95
Table 212: AQT90 - PT-INR Test - Product Description 95
Table 213: Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview 96
Table 214: Diagnostic Kit - Hypercoagulation - Product Status 96
Table 215: Diagnostic Kit - Hypercoagulation - Product Description 96
Table 216: rHealth Pipeline Products & Ongoing Clinical Trials Overview 97
Table 217: rHEALTH Coagulation Assay - Product Status 97

1.2 List of Figures
Figure 1: Haemostasis Diagnostic Tests - Pipeline Products by Stage of Development 14
Figure 2: Haemostasis Diagnostic Tests - Pipeline Products by Segment 15
Figure 3: Haemostasis Diagnostic Tests - Pipeline Products by Territory 16
Figure 4: Haemostasis Diagnostic Tests - Pipeline Products by Regulatory Path 17
Figure 5: Haemostasis Diagnostic Tests - Pipeline Products by Estimated Approval Date 18
Filed in: Medical Device
Publisher : GlobalData